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Since the early 1980s extracorporeal shock wave lithotripsy (ESWL) has 
partially replaced major operative procedures in various fields of surgery. 
In the interest of the patient, it is important to determine the exact role of 
ESWL in surgery. Comparing our own prospectively followed patients 
with other patient series, we bave tried to assess this role. We treated 133 
patients with cholecystolithiasis, 80 patients with choledocholithiasis, and 
17 patients with pancreatic stones using a second-generation lithotriptor, 
the Siemens Lithostar (Siemens, Erlangen, Germany). The results suggest 
a limited role of ESWL for cholecystolithiasis, in which it is reserved for 
patients with high operative risk and patients who reject an operation. 
For choledocholithiasis ESWL seems to become an integral part of the 
treatment in the elderly patient in whom endoscopic stone removai proved 
impossible. Finally, ESWL could become a first option for the treatment 
of intractable pain in patients with chronic calcifying pancreatitis. 
Shock waves, which can be used to disintegrate stones because 
of their physical characteristics, can be generated by three 
methods [1-3]. Since 1980 extracorporeal shock wave litho- 
tripsy (ESWL) has been used in the case of urolithiasis and has 
replaced surgical treatment almost entirely [4, 5]. ESWL of 
gallbladder stones has been applied since 1985 [6, 7], and the 
first reports on ESWL of common bile duct stones and pancre- 
atic stones appeared in 1989 [8, 9]. Despite the initial enthusi- 
asm, restrictions for ESWL of gallbladder stones especially 
soon became evident. Rigid entry criteria, expensive adjuvant 
dissolution therapy, moderate results, and the possibility of 
stone recurrence after gallbladder-preserving therapies are ma- 
jor drawbacks [7, 10-17]. ESWL of common bile duct stones is 
useful in patients in whom endoscopic removal proves impos- 
sible [8, 18-21]. ESWL of pancreatic stones in chronic calcify- 
ing pancreatitis i still relatively unknown but seems effective 
[22]. The morbidity and mortality associated with ESWL are 
minimal [7, 8, 11-13, 18-22] and compare favorably to those 
with surgery. Therefore we have tried to assess the exact role of 
ESWL in this field with our own prospectively followed pa- 
tients and other patient series. 
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Patients and Methods 
Using a so-called second-generation lithotriptor, the Siemens 
Lithostar (Siemens, Erlangen, Germany), which operates on a 
electromagnetic principle, we treated patients suffering from 
cholecystolithiasis (n = 133, group I), choledocholithiasis (n = 
80, group II), and pancreatic stones (n = 17, group III). 
Characteristics of these patients are depicted in Table 1, and 
entry criteria for ESWL in the three groups are shown in Table 
2. 
Group I 
Ail patients were treated on an outpatient basis. Directly after 
the first ESWL session, adjuvant oral bile acid (OBA) therapy 
(urso- and chenodeoxycholate) was started. Ten days after each 
session an ultrasound examination (US) was done to determine 
the fragmentation result. If fragments remained larger than 5 
mm after repeated sessions, ESWL was considered a failure, 
and cholecystectomy was advised. US was performed at regu- 
lar intervals (3 months, 6 months, 1 year, 1.5 years, and 2 years) 
after the first session. If US did not demonstrate stone material 
at two consecutive occasions, clearance of the gallbladder was 
assumed and the OBA therapy stopped. 
Group II 
All patients had one or more of the symptoms, depicted in Table 
1. The stones were visualized by radiology and injection of 
contrast medium in the bile ducts via a biliary drain (Table 1). In 
11 patients the biliary sphincter could not be reached at 
endoscopy. In those patients and in seven others, percutaneous 
drains and T tubes were used. Of the 47 patients without 
gallbladder, 12 had had a cholecystectomy recently and had 
also undergone a choledochotomy. In these patients, over- 
looked common bile duct stones were discovered on a postop- 
erative "[" tube cholangiogram. The possibility of spontaneous 
clearance of the stones after endoscopic sphincterotomy was 
thought to be low because of the large size and impacted 
character of the stones. 
All treatments were performed under antibiotic overage and 
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Table 1. Patient characteristics before ESWL treatment. 
Characteristic Group I Group II Group III 
Patients (M/F) 
Age, mean (range) 
(years) 
Stones (no. patients) 
1 
2-5 
6-10 
Stone diameter mean 
(range) (mm) 
Patients (no.) with 
ES 
Biliary drain 
NBD 
PTD 
T-tube 
Symptoms 
Biliary colic 
Jaundice 
Fever > 38.5~ 
Cholecystectomy 
Previous 
pancreatic 
surgery 
History of alcohol 
abuse 
133 (34/99) 80 (33/47) 17 (10/7) 
49 (24-81) 73 (27-91) 42 (1%55) 
70 (53%) 34 (43%) 6 (35%) 
55 (41%) 32 (40%) 7 (41%) 
8 (6%) 14 (18%) 4 (24%) 
17 (5-40) 25 (10-50) 21 (14--40) 
69 (86%) 17 (100%) 
62 (78%) 
6 (8%) 
12 (15%) 
39 (49%) 
36 (45%) 
16 (20%) 
47 (59%) 
3 (18%) 
10 (59%) 
ES: endoscopic sphincterotomy; NBD: nasobiliary drain; PTD: 
percutaneous transhepatic drain. 
Table 2. Criteria for ESWL of gallbladder, common bile duct, or 
pancreatic stones. 
Gallbladder stones 
Symptoms: biliary colics 
Opacification of gallbladder at oral cholecystography 
No. of stones: 1-10; diameter of largest stone > 5 mm 
Calcified rim of stone < 2 mm 
No cholecystitis, cholangitis, pancreatitis, hepatitis, or concomitant 
choledocholithiasis at the time of ESWL 
Common bile duct stones 
Symptoms: obstruction ofcommon bile duct (jaundice, abdominal 
pain, fever) 
Endoscopic extraction impossible 
Visualization of stones with contrast medium via a biliary drain 
Pancreatic stones 
Symptoms: recurrent abdominal pain 
Endoscopic extraction impossible 
Visualization of stones without contrast medium 
No acute pancreatitis, acute cholecystitis, cholangitis, or 
concomitant choledocholithiasis at the time of ESWL 
Gallbladder, common bile duct, and pancreatic stones 
No lung tissue, cysts, or aneurysms in the shock wave path 
No bleeding disorders 
No pregnancy 
continuous lavage of the bile ducts with 4 liters of sterile water 
per 24 hours. Shortly after ESWL the result was evaluated by 
cholangiography. In case of fragmentation (reduction of stone 
diameter, lines of contrast medium visible within the stone, or 
quick disappearance of the contrast medium from the biliary 
tree), cholangiography was repeated after 2 days of lavage. In 
the case of remaining fragments, a new endoscopic or percuta- 
neous stone extraction was attempted. If it was not successful 
Table 3. Characteristics of ESWL sessions in three groups of patients. 
Group I Group II Group III 
Characteristic (n = 133) (n = 80) (n = 17) 
Sessions/patient 2.2 (1-7) 1.9 (1-4) 1.9 (1--4) 
(range) 
SW/session 2817 (75-4000) 4703 (1200-6000) 4660 (1000-8000) 
(range) 
Duration 62 (35-210) 64 (30-150) 73 (20-105) 
(min)/ 
session 
(range) 
Patients (no.) 
GA 0 1 1 
AS 133 71 15 
No GA/AS 0 8 1 
SW: shock waves; GA: general anesthesia; AS: analgo-sedation. 
or in cases where stone fragmentation was never demonstrated, 
the patient underwent an elective bile duct exploration or had 
an endoprosthesis placed in the common bile duct. 
Group III 
The diagnosis "chronic pancreatitis" was based on the pa- 
tient's history (chronic upper abdominal pain or recurrent 
attacks of upper abdominal pain), the presence of calcifications 
in the pancreatic region on plain abdominal roentgenography, 
and the radiologic aspect of chronic pancreatitis on endoscopic 
retrograde cholangiopancreatography [23]. Ail patients were 
treated under antibiotic overage. In 15 patients the stones 
could be visualized as calcifications by radiology alone. Shock 
waves were focused on these calcifications. In 2 patients 
additional injection of contrast medium via a nasopancreatic 
drain was necessary for visualization of the stones because of a 
low calcification grade. After the ESWL treatment a plain 
abdominal roentgenogram was obtained. If stone fragmentation 
was observed (clear change of contour of stone), another 
endoscopic stone extraction was attempted, after which a 
nasopancreatic drain was left in place for lavage (2 liters sterile 
water per 24 hours). If no stone material was observed, spon- 
taneous clearance of the duct was assumed. If ESWL repeat- 
edly failed in fragmenting the stones, an operation was contem- 
plated. 
Statistics were performed using the test for comparing pro- 
portions with binominal distributions and the Wilcoxon test for 
matched pairs. 
Results 
Table 3 summarizes the characteristics of the ESWL sessions 
for all three groups of patients. Table 4 depicts the fragmenta- 
tion and clearance rates for all three groups. For group I the 
median follow-up (range) is 14 months (1--45 months), in group 
II 23 months (1-50 months), and group III 20 months (3-41 
months). 
Group I 
Stone fragmentation (decrease of diameter of the largest stone 
> 25%) could be achieved in most patients (89%)~ but after 
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Table 4. Results of ESWL of the gallbladder, common bile duct, and 
pancreatic stones. 
No 
Group fragmentation Fragmentation ~ Stone clearance 
I (n = 133) 15 (11%) 118 (89%) ~ 43 (32%) 
8 Expectant 52 Still OBA 6 Recurrence 
7 Operated 23 Operated 4 Expectant 
10perated 
1 OBA 
66 (83%) ~ 52 (65%) 
6 Endoprosth 14 Lavage 
60perated 34 Endoscopic 
electively extraction 
20perated 4 Percutaneous 
emergently extraction 
13 (76%) ~ 7 (41%) 
4 Pain All pain relief 
relief 
20perated 
II (n = 80) 14 (18%) 
Ail operated 
electively 
III (n = 17) 4 (24%) 
1 Expectant 
30perated 
OBA: oral bile acid therapy; endoprosth: endoprosthesis. 
adjuvant OBA therapy stone clearance could be achieved in 
only 32% of the patients to date. In the remainder of the 
patients, OBA therapy continues or a cholecystectomy has 
been undertaken because of persistent biliary complaints or 
insufficient stone fragmentation. Patients with a solitary stone 
had a significantly better chance to become stone-free than 
patients with multiple stones: 26 of 52 (51%) versus 5 of 60 
(13%), respectively, after 1 year of follow-up (p < 0.001: two 
sample proportion test). 
Fourteen percent of patients with stone clearance (6/43) had 
stone recurrence: four of the six were not symptomatic, one 
underwent a cholecystectomy, and in one OBA therapy was 
restarted. 
A total of 57 patients (43%) had biliary colic shortly after the 
ESWL treatment. Other complications were obstruction of the 
common bile duct in nine patients (7%), rive of whom became 
jaundiced and in four of whom pancreatitis developed. Two 
patients (1.5%) had transient hematuria, one had acute chole- 
cystitis after ESWL. OBA therapy resulted in diarhea in 15 
patients (11%), which resolved in ail cases after lowering the 
dose of OBA for 2 weeks. No mortality was observed. 
Group H 
Stone clearance was achieved in 52 patients (65%); in 14 cases 
biliary lavage was sufficient o clear the bile ducts; in 34 cases 
the remaining fragments were extracted endoscopically and in 4 
cases percutaneously. In case of failure of the additional 
endoscopic or percutaneous attempts (n = 14, 18%), the final 
treatment--taking into account he patient's physical status--  
consisted in placing an endoprosthesis past the fragmented 
Stones (n = 6) or undertaking an elective bile duct exploration 
(n = 6). In two cases emergency surgery was necessary after 
complications of an endoscopic procedure (one perforation of 
the common bile duct with a Dormia basket, one arterial 
bleeding after extension of a sphincterotomy). These two pa- 
tients had an uneventful recovery. 
Two patients (3%), one with and one without a gallbladder, 
had stone recurrence at 27 and 30 months after ESWL, respec- 
tively. The first patient could be treated with a renewed 
endoscopic extraction, and the other had a successful repeated 
ESWL treatment. 
One patient had a subcapsular hematoma of the right kidney, 
as demonstrated on US. The hematoma resolved without clin- 
ical consequences. Notwithstanding antibiotic prophylaxis, one 
patient developed sepsis with a positive blood culture (Esche- 
richia coli). This patient received adequate medical treatment. 
There was no mortality after ESWL and adjuvant reatments. 
Group III 
Thirteen patients had stone fragmentation (76%), of whom 11 
(65%) had immediate pain relief after ESWL. The other two 
patients, with fragmentation but without clearance of stones, 
had recurrent pain attacks and consequently underwent a 
side-to-side pancreatojejunostomy 12 and 24 months after 
ESWL, respectively (Table 4). Seven patients (41%) had com- 
plete stone clearance (in three the pancreatic duct cleared 
spontaneously after ESWL, and in four the duct was cleared 
after 2 days of lavage with sterilized water). To date, none has 
had recurrent abdominal pain except one patient who had a pain 
attack after a large alcohol intake. The median follow-up of 
these seven patients was 22 months (6-41 months). Of the four 
patients without stone fragmentation, three had a side-to-side 
pancreaticojejunostomy. However, ail three of them still report 
abdominal pain 38, 31, and 14 months after the operation, 
respectively. One has developed insulin-dependent diabetes 
mellitus. 
The only complication directly after ESWL was an exacer- 
bation of pancreatitis in one patient that could be treated 
medically. Again, there was no mortality after ESWL. 
Discuss ion 
The role of ESWL in surgery is becoming clarified. With the 
results achieved in our patients and in other patient series, more 
reasoned statements can be made now. In~tead of optimistic or 
pessimistic views, patients benefit most from a weU established 
treatment schemœ in which the different modalities have their 
own, though sometimes limited, role. 
Gallbladder Stones 
(Laparoscopic) cholecystectomy remains the gold standard as 
the treatment for symptomatic holecystolithiasis [24, 25]. 
Cholecystectomy carries morbidity and mortality rates of about 
10% to 30% and 0.1% to 0.3%, respectively, and these rates 
increase with age [25]. With laparoscopic holecystectomy 
these figures may be lower, but the higher incidence of bile duct 
injuries gives reason for concern [26]. There is no reported 
mortality associated with ESWL of gallbladder stones, and the 
rate of major complications i low [7, 11]. In our series, nine 
patients (7%) had common bile duct obstruction, and one 
patient had an acute cholecystitis after ESWL. 
After optimistic initial reports in which finally more than 90% 
of the selected patients became stone-free [7], less favorable 
results gave fise to pessimistic omments [27]. However, most 
patient series have reported overall stone-free rates at 12 
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months of 30% to 84%, depending largely on stone character- 
istics [10-14, 28-31]. This point is in accordance with our own 
findings--that ESWL therapy is found to be more effective for 
solitary than multiple stones, for radiolucent han slightly 
calcified stones, and for smaller than for larger stones. In view 
of the above, we think that only patients with a high operative 
risk (ASA classification I I I - IV [32]) or patients who reject an 
operation should undergo ESWL, provided they comply with 
strict criteria to achieve the highest possible stone clearance 
rate. We estimate this rate to be about 50% after 1 year. 
Common Bile Duct Stones 
In the case of choledocholithiasis, surgical common bile duct 
exploration is an accepted therapy but carries a considerable 
mortality rate, which may be as high as 8% in the elderly or in 
high-risk patients [33-35]. Among this population, the treatment 
of choice is endoscopic sphincterotomy (ES) [36--38]. However, 
in about 10% of the cases it proves impossible to clear the bile 
ducts with endoscopy alone [8, 36, 39]. The natural history of 
common bile duct stones, with or without ES, still is not well 
known [37]. However, ail our patients were symptomatic and 
needed therapy for the short term. In these patients ESWL is an 
attractive alternative to surgery: Stone clearance was achieved 
in 65% of our patients and in up to 88% in other studies [8, 
18-21, 40, 41]. 
The failure rate can be due to the possibility of false positivity 
during radiologic targeting via a biliary drain. The morbidity 
rate of ESWL of common bile duct stones is low: Macrohema- 
turia (in 2-11% of the patients) and hemobilia (2-8%) are 
reported to resolve within a few days [8, 18, 20]. Septic fever in 
3% to 6% of the cases is often regarded as an exacerbation of 
already existing cholangitis [8, 18, 19]. There has not been any 
ESWL-related mortality, but mortality associated with the 
adjuvant endoscopic or percutaneous procedures, which is 
about 1% [36, 39], must be borne in mind. At least in the patient 
with an increased operative risk, ESWL should be considered 
before surgery after failure of endoscopic measures. 
Pancreatic Stones 
Although it remains uncertain whether pancreatic stones are the 
main cause of the pain in chronic calcifying pancreatitis (CCP), 
11 of 13 patients with stone fragmentation were free of abdom- 
inal pain directly after the ESWL treatment (Table 4). Whether 
fragmentation without stone clearance can lead to long-lasting 
pain relief is doubtful. In our series two of six patients with 
stone fragmentation but no stone clearance had recurrent 
abdominal pain and an operation after ESWL. The other four 
patients have reported pain relief only at limited follow-up 
(median 7 months, range 5-10 months). ESWL resulted in 
clearance of stone material in 41% of our patients, and all of 
them have pain relief to date. 
Stone clearance in 59% of 123 patients with CCP, treated with 
ESWL and subsequent endoscopic drainage, has been reported 
[22]. The authors emphasized the importance of deep endo- 
scopic drainage in the pancreatic duct after ESWL. 
The ESWL technique compares favorably with an operation 
for pain relief in CCP: It is noninvasive, there is no need for 
general anesthesia, no mortality has been reported, and the 
number of complications i low (in our series one exacerbation 
of pancreatitis). It is unlikely that pancreatic insufficiency will 
be induced by ESWL. Furthermore, the hospitalization time is 
short (about 3 days per ESWL session). Pancreatic surgery is 
accompanied by considerable morbidity and mortality (rates of 
20-40% and 2-5%, respectively) [42, 43]. In large surgical 
series, long-lasting pain relief cannot be achieved in 20% to 40% 
of the cases [42-46]. In view of the above, a randomized trial 
comparing ESWL with surgery or the natural history of this 
disease is warranted. 
In conclusion, if a decision must be made about whether to 
operate on a patient with CCP or treat him or her with ESWL 
followed by endoscopic drainage, we think that ESWL is the 
better alternative. It seems important o achieve stone clear- 
ance and not mere stone fragmentation. Of course abuse of 
alcohol must be treated as a condition that may interfere with 
the success of this therapy of CCP. 
R›233 
Pendant ces 12 derniš ann› la lithotritie extracorporelle 
(LE) a ›233 propos› pour remplacer certaines techniques chir- 
urgicales. Dans l'int›234 du patient, il › important de d› 
miner le r¤ pr› de la LE en chirurgie. Nous avons suivi 
prospectivement 133 patients ayant une lithiase v› 80, 
une lithiase de la voie biliaire principale et 17, des calcificatins 
pancr› tous trait› par un lithotriteur de deuxiš 
g›233 le Siemens Lithostar (Siemens, Erlangen, RFA). 
Les r› sugg› que la LE a un r¤ limit› dans la 
lithiase v› r›233 uniquement aux les patients ” trš 
haut risque chirurgical et ” ceux qui refusent l'intervention. 
Chez les patients ayant une lithiase de la voie biliaire principale, 
son r¤ se borne au traitement des patients –233 inop› 
chez lequels la sphinct› est un › Enfin, la LE 
pourrait œ le traitement de choix chez les patients ayant des 
douleurs r› au traitement m› dans la pancr› 
calcifiante chronique. 
Resumen 
A partir de 1980 la litroticia extracorp6rea por ondas de shock 
(LEOS) ha sido eficazmente utilizada en la urolitiasis y ha 
venido a suplantar casi totalmente al tratamiento quirtirgico. La 
LEOS de cfilculos de la vesicula biliar estfi en uso desde 1985, 
y los primeros informes obre LEOS de cfilculos del col› y 
del pfincreas aparecieron en 1989. A pesar del entusiasmo 
inicial, bien pronto se hicieron evidentes las restricciones sobre 
su aplicaci6n, especialmente n el caso de cfilculos de la 
vesfcula biliar. En el inter› del paciente, aparece importante 
definir el papel de la LEOS en la cirugia. Hemos tratado de 
hacerlo comparando nuestros pacientes, seguidos en forma 
prospectiva, con los de otras series. Nuestro grupo ha tratado 
133 casos de colelitiasis, 80 de coledocolitiasis y 17 de c~lculos 
pancrefiticos con un litotritor de segunda generaci6n, el Lithos- 
tar de Siemens (Siemens, Erlangen, Alemania). Los resultados 
sugieren un papei limitado de la LEOS en colelitiasis, entidad 
para la cual se usa s61o en pacientes de muy alto riesgo 
operatorio o en aquellos que rehusan la operaci6n. En la 
coledocolitiasis la LEOS aparece como parte integral del trat- 
amiento en pacientes de edad avanzada, en quienes resulte 
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imposible la remoci rn  endosc6pica de los c(dculos. Finalmente, 
la LEOS puede representar la primera opci6n en el manejo del 
dolor intratable en pacientes con pancreatitis crrnica calcifi- 
cada. 
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